Yahoo Finance host Brad Smith tracks today's top moving stocks and biggest market stories in this Market Minute, including ...

The triumph of Ozempic, Wegovy, and related drugs, including Lilly’s Zepbound, has set off a push toward the next frontier: a ...

Dave Moore, senior vice president of U.S. operations at Novo Nordisk, says his company wants to “meet patients where they are.” ...

Listen below or on the go on Apple Podcasts and SpotifyThis is an abridged transcript of the podcast.Companies looking to ...

CVS Health sees strong Q1 2025 growth, but risks loom with downgraded revenue guidance and Medicare challenges. Read my ...

With President Trump's on-off tariffs causing huge uncertainty in recent weeks, some value stocks have been getting even ...

Microsoft and Meta's strong earnings reports eased investor fears of an economic slowdown amid President Trump's tariffs.

Wegovy is likely to have been the key top-line ... that caused the stock price to slide are likely to be temporary, and we remain confident that NVO is a good stock to retain.

Roberts passes the time in the weigh-in queue chatting to women aged from 20- to 70-something in a community centre in West ...

Currently, Novo has only injectable GLP-1 drugs on the market -- Ozempic and Wegovy -- and Viking has neither.) Long story short, investors in Eli Lilly stock are right to be excited today.